A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

Source:http://linkedlifedata.com/resource/pubmed/id/11803085

Vaccine 2002 Jan 15 20 7-8 1226-31

Download in:

View as

General Info

PMID
11803085